By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Bellicum Pharmaceuticals, Inc. 

2 Greenway Plaza
Suite 1380
Houston  Texas  77046  U.S.A.
Phone: 713-798-8670 Fax: 713-798-4950



Company News
Bellicum (BLCM) Announces Late-Breaking Poster Presentation On TCR Product Candidate With Activation Switch At The AACR 2016 Annual Meeting 4/18/2016 11:05:12 AM
Bellicum (BLCM) Announces BPX-501 Clinical Data Updates 4/5/2016 10:40:28 AM
Bellicum (BLCM) Provides Operational Update And Reports Financial Results For Fourth Quarter And Year Ended December 31, 2015 3/15/2016 10:36:26 AM
Bellicum (BLCM) To Present At The Barclays Global Healthcare Conference 3/8/2016 10:14:16 AM
Bellicum (BLCM) To Report Fourth Quarter And Full Year 2015 Financial Results And Host Conference Call And Webcast On March 14, 2016 3/3/2016 11:01:25 AM
FDA Grants Orphan Drug Designation To Bellicum (BLCM)’s BPX-501 For The Treatment Of Immunodeficiency And GvHD Following Stem Cell Transplant 2/22/2016 12:56:45 PM
Bellicum (BLCM) Announces Submission Of BPX-701 And BPX-601 Clinical Trial Protocols For Review By The NIH RAC 1/11/2016 11:16:34 AM
Bellicum (BLCM) To Be Added To The NASDAQ Biotechnology Index 12/15/2015 12:01:18 PM
Bellicum (BLCM) And Astellas (ALPMY) Announce License Agreement For Cancer Target PSCA In Cell And Gene Therapy 12/11/2015 10:48:44 AM
Bellicum (BLCM) Announces Oral Presentation At American Society of Hematology Showing Improved Potency And Control With CIDeCAR T-Cell Therapies 12/8/2015 12:51:16 PM